Stockscreener 앱 받기
23.25
1.48%
0.34
시장 영업 전:
23.38
0.13
+0.56%
Zymeworks Inc. 주식(ZYME)의 최신 뉴스
Zymeworks to Spotlight Pipeline and Portfolio at Series of Major Healthcare Investor Conferences - TipRanks
Biotech firm Zymeworks lines up 4 investor events through March - Stock Titan
Aug Volume: Should I set a stop loss on MOFGWeekly Investment Report & Weekly Momentum Picks - baoquankhu1.vn
Stop Loss: Can BHST expand its profit marginsJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Zymeworks Inc. (ZYME) Stock Analysis: Strong Buy Ratings and a Promising 51% Upside Potential - DirectorsTalk Interviews
Analyst Upgrade: Does Zymeworks Inc have strong EBITDA marginsPortfolio Risk Summary & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Does Zymeworks’ HERIZON-GEA-01 Win And Milestone Potential Change The Bull Case For ZYME? - Sahm
Analysts Are Bullish on Top Healthcare Stocks: Zymeworks (ZYME), Centessa Pharmaceuticals (CNTA) - The Globe and Mail
Zymeworks to Showcase Innovative Biotherapeutics at Upcoming Conferences - MSN
A Look At Zymeworks (ZYME) Valuation After Positive HERIZON GEA 01 Trial Results And Royalty Milestone Potential - Sahm
New Highs: Can Hippo Holdings Inc lead its sector in growthQuarterly Risk Review & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Aug Analyst Calls: What is the earnings history of Zymeworks IncJuly 2025 Momentum & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Zymeworks (NYSE:ZYME) Shares Down 5.5%Here's Why - MarketBeat
Hollywood mark, EVP at Zymeworks, sells $138k in shares By Investing.com - Investing.com Nigeria
Zymeworks (NYSE:ZYME) COO Mark Hollywood Sells 6,120 Shares - MarketBeat
Hollywood mark, EVP at Zymeworks, sells $138k in shares - Investing.com
Zymeworks appoints industry veteran Brian Cherry to board By Investing.com - Investing.com Nigeria
Zymeworks Inc. (NASDAQ:ZYME) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Zymeworks CSO Moore sells $216k in shares By Investing.com - Investing.com UK
Zymeworks (NYSE:ZYME) EVP Jeffrey Smith Sells 9,310 Shares - MarketBeat
Zymeworks (NYSE:ZYME) Insider Paul Andrew Moore Sells 9,560 Shares - MarketBeat
Zymeworks EVP Smith sells shares for $211,090 By Investing.com - Investing.com Australia
Zymeworks EVP Smith sells shares for $211,090 - Investing.com
Zymeworks CSO Moore sells $216k in shares - Investing.com
Insider Selling: Zymeworks (NYSE:ZYME) CEO Sells 30,424 Shares of Stock - MarketBeat
Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy - The Globe and Mail
What's Driving Zymeworks Stock Higher? - Nasdaq
Zymeworks Makes Leadership, Board Changes; Begins CFO Search - marketscreener.com
Zymeworks Reshapes Board and Executive Team to Support Next Phase of Growth - TipRanks
Zymeworks appoints industry veteran Brian Cherry to board - Investing.com
Zymeworks Inc. Announces Chief Financial Officer Changes - marketscreener.com
Biotech Zymeworks shakes up its top team as it refocuses strategy - Stock Titan
HERIZON-GEA-01 Trial Highlights Zymeworks’ Path To $440M Milestones And Growth (ZYME) - Seeking Alpha
Zymeworks (ZYME) Reports Positive Phase 3 Trial Results for Ziih - GuruFocus
Zymeworks reports positive phase 3 Ziihera data; cash runway extended beyond 2028 - Seeking Alpha
Zymeworks Sets 2026 Strategy on Zanidatamab Momentum, ADC Pipeline and Cash-Fueled Growth - TipRanks
Zymeworks Reports Positive Phase 3 Results for Ziihera® in HER2-Positive Gastroesophageal Adenocarcinoma, Announcing Strategic Priorities for 2026 - Quiver Quantitative
Zymeworks Outlines Strategic Priorities and Outlook for 2026 - The Manila Times
Zymeworks outlines strategic priorities and outlook for 2026 - marketscreener.com
Zymeworks Inc. - Via Ritzau
Aug Macro: Is Zymeworks Inc. stock vulnerable to regulatory risksQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - ulpravda.ru
Can Zymeworks Inc. stock hit analyst price targetsWeekly Volume Report & Weekly Top Performers Watchlists - Улправда
Zymeworks Inc. (ZYME) Stock Analysis: A 53.85% Potential Upside In The Biotech Arena - DirectorsTalk Interviews
Earnings Beat: How Zymeworks Inc stock reacts to oil pricesJuly 2025 Analyst Calls & Safe Entry Trade Signal Reports - moha.gov.vn
How Zymeworks Inc. stock reacts to oil pricesShare Buyback & Weekly Stock Performance Updates - Улправда
Zymeworks (ZYME) Is Down 5.6% After Positive Phase 3 Ziihera Data Unlocks US$440 Million Milestones - simplywall.st
Will Zymeworks Inc. stock benefit from upcoming earnings reportsTrend Following Strategies & Affordable Trading Plans - ulpravda.ru
Oklahoma City NewsThe Oklahoman - FinancialContent
Jazz Pharmaceuticals' Drug Extends Survival Past Two Years in Advanced Stomach Cancer Trial - Benzinga
2.09%
0.48%
자본화:
|
볼륨(24시간):